Valbenazine (Synonyms: NBI-98854) |
Catalog No.GC19370 |
La valbénazine (NBI-98854) est un inhibiteur du transporteur vésiculaire de la monoamine 2 (VMAT2) avec un Ki de 110-190 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1025504-45-3
Sample solution is provided at 25 µL, 10mM.
Valbenazine is a prodrug of the (+)-α isomer of tetrabenazine for tardive syndrome therapy, and inhibits VMAT2 function.
Valbenazine shows a distinctive improvement in tardive dyskinesia symptoms during the successful Phase II trial[1].
References:
[1]. Müller T, et al. Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Expert Opin Investig Drugs. 2015 Jun;24(6):737-42.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *